IBDEI07S ; ; 18-FEB-2009
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 18, 2009
 Q:'DIFQR(358.3)  F I=3D1:2 S X=3D$T(Q+I) Q:X=3D""  S
Y=3D$E($T(Q+I+1),4,999),X=3D$E(X,4,999) S:$A(Y)=3D126
I=3DI+1,Y=3D$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=3D61 Y=3D$E(Y,2,999) =
X NO E
S @X=3DY
Q Q
 ;;^UTILITY(U,$J,358.3,8286,0)
 ;;=3D438.20^^67^567^9.1
 ;;^UTILITY(U,$J,358.3,8286,1,0)
 ;;=3D^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8286,1,2,0)
 ;;=3D2^438.20
 ;;^UTILITY(U,$J,358.3,8286,1,5,0)
 ;;=3D5^Late Eff of Stroke & Hemiplegia/paresis, unspec
 ;;^UTILITY(U,$J,358.3,8286,2)
 ;;=3DLate Eff of Stroke & Hemiplegia/paresis, unspec^317910
 ;;^UTILITY(U,$J,358.3,8287,0)
 ;;=3D438.21^^67^567^9.2
 ;;^UTILITY(U,$J,358.3,8287,1,0)
 ;;=3D^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8287,1,2,0)
 ;;=3D2^438.21
 ;;^UTILITY(U,$J,358.3,8287,1,5,0)
 ;;=3D5^Late Eff of Stroke & Hemiplegia/paresis, domin
 ;;^UTILITY(U,$J,358.3,8287,2)
 ;;=3DStroke & Hemiplegia/paresis, domin^317911
 ;;^UTILITY(U,$J,358.3,8288,0)
 ;;=3D438.22^^67^567^9.3
 ;;^UTILITY(U,$J,358.3,8288,1,0)
 ;;=3D^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8288,1,2,0)
 ;;=3D2^438.22
 ;;^UTILITY(U,$J,358.3,8288,1,5,0)
 ;;=3D5^Late Effect, Stroke & Hemiplegia/paresis, non-dom
 ;;^UTILITY(U,$J,358.3,8288,2)
 ;;=3DLate Effect, Stroke & Hemiplegia/paresis, non-dom^317912
 ;;^UTILITY(U,$J,358.3,8289,0)
 ;;=3D138.^^67^567^15
 ;;^UTILITY(U,$J,358.3,8289,1,0)
 ;;=3D^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8289,1,2,0)
 ;;=3D2^138.
 ;;^UTILITY(U,$J,358.3,8289,1,5,0)
 ;;=3D5^Post Polio Syndrome
 ;;^UTILITY(U,$J,358.3,8289,2)
 ;;=3DPost Polio Syndrome^266979
 ;;^UTILITY(U,$J,358.3,8290,0)
 ;;=3D191.9^^67^567^2
 ;;^UTILITY(U,$J,358.3,8290,1,0)
 ;;=3D^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8290,1,2,0)
 ;;=3D2^191.9
 ;;^UTILITY(U,$J,358.3,8290,1,5,0)
 ;;=3D5^Brain Tumor, Unspecified
 ;;^UTILITY(U,$J,358.3,8290,2)
 ;;=3D^267279
 ;;^UTILITY(U,$J,358.3,8291,0)
 ;;=3D437.9^^67^567^16
 ;;^UTILITY(U,$J,358.3,8291,1,0)
 ;;=3D^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8291,1,2,0)
 ;;=3D2^437.9
 ;;^UTILITY(U,$J,358.3,8291,1,5,0)
 ;;=3D5^Cerebrovascular Disease,Unspec
 ;;^UTILITY(U,$J,358.3,8291,2)
 ;;=3D^21803
 ;;^UTILITY(U,$J,358.3,8292,0)
 ;;=3D310.1^^67^568^7
 ;;^UTILITY(U,$J,358.3,8292,1,0)
 ;;=3D^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8292,1,2,0)
 ;;=3D2^310.1
 ;;^UTILITY(U,$J,358.3,8292,1,5,0)
 ;;=3D5^Organic Memory Loss
 ;;^UTILITY(U,$J,358.3,8292,2)
 ;;=3DOrganic Memory Loss^268318
 ;;^UTILITY(U,$J,358.3,8293,0)
 ;;=3D435.9^^67^568^8
 ;;^UTILITY(U,$J,358.3,8293,1,0)
 ;;=3D^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8293,1,2,0)
 ;;=3D2^435.9
 ;;^UTILITY(U,$J,358.3,8293,1,5,0)
 ;;=3D5^TIA
 ;;^UTILITY(U,$J,358.3,8293,2)
 ;;=3D^21635
 ;;^UTILITY(U,$J,358.3,8294,0)
 ;;=3D434.90^^67^568^6
 ;;^UTILITY(U,$J,358.3,8294,1,0)
 ;;=3D^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8294,1,2,0)
 ;;=3D2^434.90
 ;;^UTILITY(U,$J,358.3,8294,1,5,0)
 ;;=3D5^Acute Cerebral Artery Occlusion Unspec
 ;;^UTILITY(U,$J,358.3,8294,2)
 ;;=3D^295808
 ;;^UTILITY(U,$J,358.3,8295,0)
 ;;=3D907.0^^67^568^1
 ;;^UTILITY(U,$J,358.3,8295,1,0)
 ;;=3D^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8295,1,2,0)
 ;;=3D2^907.0
 ;;^UTILITY(U,$J,358.3,8295,1,5,0)
 ;;=3D5^Brain Injury, Late Eff.
 ;;^UTILITY(U,$J,358.3,8295,2)
 ;;=3D^68489
 ;;^UTILITY(U,$J,358.3,8296,0)
 ;;=3DV45.81^^67^568^3
 ;;^UTILITY(U,$J,358.3,8296,1,0)
 ;;=3D^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8296,1,2,0)
 ;;=3D2^V45.81
 ;;^UTILITY(U,$J,358.3,8296,1,5,0)
 ;;=3D5^CABG, status post
 ;;^UTILITY(U,$J,358.3,8296,2)
 ;;=3D^97129
 ;;^UTILITY(U,$J,358.3,8297,0)
 ;;=3D438.11^^67^568^9
 ;;^UTILITY(U,$J,358.3,8297,1,0)
 ;;=3D^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8297,1,2,0)
 ;;=3D2^438.11
 ;;^UTILITY(U,$J,358.3,8297,1,5,0)
 ;;=3D5^Late Effect of Stroke w/Aphasia
 ;;^UTILITY(U,$J,358.3,8297,2)
 ;;=3DLate Effect of Stroke w/Aphasia^317907
 ;;^UTILITY(U,$J,358.3,8298,0)
 ;;=3D438.12^^67^568^10
 ;;^UTILITY(U,$J,358.3,8298,1,0)
 ;;=3D^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8298,1,2,0)
 ;;=3D2^438.12
 ;;^UTILITY(U,$J,358.3,8298,1,5,0)
 ;;=3D5^Late Effect of Stroke w/Dysphasia
 ;;^UTILITY(U,$J,358.3,8298,2)
 ;;=3D^317908
 ;;^UTILITY(U,$J,358.3,8299,0)
 ;;=3D438.82^^67^568^11
 ;;^UTILITY(U,$J,358.3,8299,1,0)
 ;;=3D^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8299,1,2,0)
 ;;=3D2^438.82
 ;;^UTILITY(U,$J,358.3,8299,1,5,0)
 ;;=3D5^Late Effect of Stroke w/Dysphagia
 ;;^UTILITY(U,$J,358.3,8299,2)
 ;;=3DLate Effect of Stroke w/Dysphagia^317923
 ;;^UTILITY(U,$J,358.3,8300,0)
 ;;=3D438.20^^67^568^12
 ;;^UTILITY(U,$J,358.3,8300,1,0)
 ;;=3D^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8300,1,2,0)
 ;;=3D2^438.20
 ;;^UTILITY(U,$J,358.3,8300,1,5,0)
 ;;=3D5^Late Effect of Stroke w/Hemiplegia/paresis
 ;;^UTILITY(U,$J,358.3,8300,2)
 ;;=3DLate Effect of Stroke w/Hemiplegia/paresis^317910
 ;;^UTILITY(U,$J,358.3,8301,0)
 ;;=3D434.91^^67^568^2
 ;;^UTILITY(U,$J,358.3,8301,1,0)
 ;;=3D^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8301,1,2,0)
 ;;=3D2^434.91
 ;;^UTILITY(U,$J,358.3,8301,1,5,0)
 ;;=3D5^CVA, Acute
 ;;^UTILITY(U,$J,358.3,8301,2)
 ;;=3D^295738
 ;;^UTILITY(U,$J,358.3,8302,0)
 ;;=3D780.93^^67^568^13
 ;;^UTILITY(U,$J,358.3,8302,1,0)
 ;;=3D^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8302,1,2,0)
 ;;=3D2^780.93
 ;;^UTILITY(U,$J,358.3,8302,1,5,0)
 ;;=3D5^Memory Loss NOS
 ;;^UTILITY(U,$J,358.3,8302,2)
 ;;=3D^329952
 ;;^UTILITY(U,$J,358.3,8303,0)
 ;;=3D250.70^^67^569^3
 ;;^UTILITY(U,$J,358.3,8303,1,0)
 ;;=3D^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8303,1,2,0)
 ;;=3D2^250.70
 ;;^UTILITY(U,$J,358.3,8303,1,5,0)
 ;;=3D5^DM II w/Vascular Disease
 ;;^UTILITY(U,$J,358.3,8303,2)
 ;;=3DDM II w/Vascular Disease^267843^443.81
 ;;^UTILITY(U,$J,358.3,8304,0)
 ;;=3D457.1^^67^569^1
 ;;^UTILITY(U,$J,358.3,8304,1,0)
 ;;=3D^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8304,1,2,0)
 ;;=3D2^457.1
 ;;^UTILITY(U,$J,358.3,8304,1,5,0)
 ;;=3D5^Chronic lymphedema
 ;;^UTILITY(U,$J,358.3,8304,2)
 ;;=3D^87693
 ;;^UTILITY(U,$J,358.3,8305,0)
 ;;=3D782.3^^67^569^4
 ;;^UTILITY(U,$J,358.3,8305,1,0)
 ;;=3D^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8305,1,2,0)
 ;;=3D2^782.3
 ;;^UTILITY(U,$J,358.3,8305,1,5,0)
 ;;=3D5^Edema
 ;;^UTILITY(U,$J,358.3,8305,2)
 ;;=3D^38340
 ;;^UTILITY(U,$J,358.3,8306,0)
 ;;=3D443.9^^67^569^7
 ;;^UTILITY(U,$J,358.3,8306,1,0)
 ;;=3D^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8306,1,2,0)
 ;;=3D2^443.9
 ;;^UTILITY(U,$J,358.3,8306,1,5,0)
 ;;=3D5^Periph Vascular Disease
 ;;^UTILITY(U,$J,358.3,8306,2)
 ;;=3D^184182
 ;;^UTILITY(U,$J,358.3,8307,0)
 ;;=3D454.9^^67^569^10
 ;;^UTILITY(U,$J,358.3,8307,1,0)
 ;;=3D^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8307,1,2,0)
 ;;=3D2^454.9
 ;;^UTILITY(U,$J,358.3,8307,1,5,0)
 ;;=3D5^Varicose Veins, Leg
 ;;^UTILITY(U,$J,358.3,8307,2)
 ;;=3D^125437
 ;;^UTILITY(U,$J,358.3,8308,0)
 ;;=3D459.81^^67^569^11
 ;;^UTILITY(U,$J,358.3,8308,1,0)
 ;;=3D^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8308,1,2,0)
 ;;=3D2^459.81
 ;;^UTILITY(U,$J,358.3,8308,1,5,0)
 ;;=3D5^Venous Insufficiency, Unspec
 ;;^UTILITY(U,$J,358.3,8308,2)
 ;;=3D^125826
 ;;^UTILITY(U,$J,358.3,8309,0)
 ;;=3D250.60^^67^569^2
 ;;^UTILITY(U,$J,358.3,8309,1,0)
 ;;=3D^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8309,1,2,0)
 ;;=3D2^250.60
 ;;^UTILITY(U,$J,358.3,8309,1,5,0)
 ;;=3D5^DM II w/Neuropathy
 ;;^UTILITY(U,$J,358.3,8309,2)
 ;;=3DDM II w/Neuropathy^267841^357.2
 ;;^UTILITY(U,$J,358.3,8310,0)
 ;;=3D250.80^^67^569^3.5
 ;;^UTILITY(U,$J,358.3,8310,1,0)
 ;;=3D^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8310,1,2,0)
 ;;=3D2^250.80
 ;;^UTILITY(U,$J,358.3,8310,1,5,0)
 ;;=3D5^DM II w/ LE Ulcer
 ;;^UTILITY(U,$J,358.3,8310,2)
 ;;=3DDM II w/ LE Ulcer^267846^707.10
 ;;^UTILITY(U,$J,358.3,8311,0)
 ;;=3D707.9^^67^569^8
 ;;^UTILITY(U,$J,358.3,8311,1,0)
 ;;=3D^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8311,1,2,0)
 ;;=3D2^707.9
 ;;^UTILITY(U,$J,358.3,8311,1,5,0)
 ;;=3D5^Ulcer Foot/Lower Limb,Unspec
 ;;^UTILITY(U,$J,358.3,8311,2)
 ;;=3DUlcer, Non Diabetic^24439
 ;;^UTILITY(U,$J,358.3,8312,0)
 ;;=3D710.0^^67^569^6
 ;;^UTILITY(U,$J,358.3,8312,1,0)
 ;;=3D^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8312,1,2,0)
 ;;=3D2^710.0
 ;;^UTILITY(U,$J,358.3,8312,1,5,0)
 ;;=3D5^Systemic Lupus Erythematosus
 ;;^UTILITY(U,$J,358.3,8312,2)
 ;;=3DSystemic Lupus Erythematosus^72159^
 ;;^UTILITY(U,$J,358.3,8313,0)
 ;;=3D714.0^^67^569^7.5
 ;;^UTILITY(U,$J,358.3,8313,1,0)
 ;;=3D^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8313,1,2,0)
 ;;=3D2^714.0
 ;;^UTILITY(U,$J,358.3,8313,1,5,0)
 ;;=3D5^Rheumatoid Arthritis
 ;;^UTILITY(U,$J,358.3,8313,2)
 ;;=3DRheumatoid Arthritis^10473^
